(July 25, 2024) – TheNewswire – Vancouver, BC - Femto Technologies Inc. (Nasdaq: BCAN) (“Femto” or the “Company”), a leading innovator in the FemTech industry, is excited to announce the debut of its flagship feminine wellness product at The AVN Expo, scheduled to take place in Las Vegas this January 2025. Femto groundbreaking product is set to redefine the standards of feminine care and wellness, showcasing its proprietary SRS (Smart Release System) technology utilizing advanced sensors that precisely detect, infuse and personalize wellness substances aiming to support intimacy and wellbeing. Femto's commitment to enhancing women's health and wellbeing through cutting-edge technology is leading the company's innovation pipeline and growth route.

 

Event: The AVN Expo

Date: January 2025

Location: Las Vegas, Nevada

 

Femto has rapidly emerged as a pioneer in the FemTech sector, dedicated to addressing the unique health and wellness needs of women through innovative and scientifically-backed solutions. The introduction of its flagship product marks a significant milestone in the company's journey to empower women and improve their quality of life.

 

AVN is a leading adult entertainment Expo bringing together 500+ adult brands alongside content creators, Femto will be presenting in the ANE section open to qualified industry members, leading vendors and top buyers. The AVN Expo, renowned for its diverse array of exhibitors and forward-thinking atmosphere, provides the perfect platform for Femto to unveil its latest innovation. Attendees will have the opportunity to experience firsthand the advanced features and benefits of Femto's new product, which has been designed with the highest standards of quality, safety, and effectiveness in mind

 

"We are thrilled to launch our flagship product at The AVN Expo, a premier event that celebrates innovation and excellence," explained Yftah ben Yaackov, CEO of Femto. "Our team has worked tirelessly to develop a solution that not only meets but exceeds the expectations of technology driven personalization for women"

 

Key highlights of Femto's flagship product include:

 

Advanced Technology: Integrating the latest in FemTech innovation to provide superior wellness support.

User-Centric Design: Engineered to cater to the specific needs and preferences of women.

Holistic Wellness: Promoting overall wellbeing through comprehensive care solutions.

 

Femto invites all attendees, media representatives, and industry professionals to visit their booth at The AVN Expo to learn more about their pioneering product and explore the future of feminine wellness.

 

For more information about Femto and their groundbreaking FemTech products, please visit www.femtocorp.com.

About Femto Technologies Inc.

 

Femto, previously known as BYND Cannasoft, aims to become serve a beacon of transformative change in the sphere of female health and wellness. Through proprietary Smart Release Technology and a dedication to creating smart, women-centric products, Femto is establishing new benchmarks in the wellness industry.

Femto is an Israeli-based integrated software company. Femto owns and markets "Benefit CRM", a proprietary customer relationship management (CRM) software product enabling small and medium‐sized businesses to optimize their day‐to‐day business activities such as sales management, personnel management, marketing, call center activities, and asset management.

Femto owns the patent-pending intellectual property for the EZ-G device. This therapeutic device uses proprietary software to regulate the flow of low concentrations of CBD oil, hemp seed oil, and other natural oils into the soft tissues of the female reproductive system to potentially treat a wide variety of women's health issues. The EZ-G device includes technological advancements as a sex toy with a more realistic experience and the prototype utilizes sensors to determine what enhances the users' pleasure. The user can control the device through a Bluetooth app installed on a smartphone or other portable device. The data will be transmitted and received from the device to and from the secure cloud using artificial intelligence (AI). The data is combined with other antonymic user preferences to improve its operation by increasing sexual satisfaction. Commercialization of the EZ-G device is subject to receipt of regulatory approvals.

The devices described in this news release are concept devices that are in the first stage of development and will be subject to testing, experiments and regulatory approvals and therefore there is no certainty that they will eventually be marketed.

For further information please refer to the Company’s new website: www.femtocorp.com and on SEDAR+: www.sedarplus.ca.

  

Gabi Kabazo

Chief Financial Officer

Tel: (604) 833-6820

e‐mail: ir@femtocorp.com

 

Cautionary Note Regarding Forward-Looking Statements

This press release includes certain statements that may be deemed “forward-looking statements” within the meaning of Section 27A of the U.S. Securities Act of 1933, as amended, and Section 21E of the U.S. Securities Exchange Act of 1934, as amended and under Canadian securities laws. When used in this press release, the words “may”, “would”, “could”, “will”, “intend”, “plan”, “anticipate”, “believe”, “estimate”, “expect” and similar expressions are intended to identify forward‐looking statements. Such statements are subject to certain risks and uncertainties, and actual circumstances, events or results may differ materially from those projected in such forward-looking statements.

Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance, and actual events or developments may differ materially from those in forward-looking statements. Such forward-looking statements necessarily involve known and unknown risks and uncertainties, which may cause the Company’s actual performance and financial results in future periods to differ materially from any projections of future performance or results expressed or implied by such forward-looking statements. Such statements reflect the Company's current views with respect to future events and are subject to such risks and uncertainties. Many factors could cause actual results to differ materially from the statements made, including future financial performance, unanticipated regulatory requests and delays, final patents approval, and those factors discussed in filings made by the company with the Canadian securities regulatory authorities, including (without limitation) in the company's management's discussion and analysis for the year ended December 31, 2023 and annual information form dated April 2, 2024, which are available under the company's profile at www.sedarplus.ca, and in the Company’s Annual Report on Form 20-F for the year then ended that was filed with the U.S. Securities and Exchange Commission on April 3, 2024. Should one or more of these factors occur, or should assumptions underlying the forward-looking statements prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, or expected. We do not intend and do not assume any obligation to update these forward‐looking statements, except as required by law. Any such forward-looking statements represent management's estimates as of the date of this press release. While we may elect to update such forward-looking statements at some point in the future, we disclaim any obligation to do so, even if subsequent events cause our views to change. Shareholders are cautioned not to put undue reliance on such forward‐looking statements.